Kids Digest Chewable
Natural health product licensed in Canada
- Licence holder
- Enzymedica Inc.
- NPN or DIN-HM
- 80039979
- Status
- Active licence
- Licence date
- 19 February 2013
- Revision date
- Not provided
- Form
- Comprimé, à croquer
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Poly(1,4-alpha-D-galacturonide) lyase Source : Aspergillus niger - En entier | 20 Endo-PG | Not calculated |
| Poly(1,4-alpha-D-galacturonide) lyase Source : Aspergillus niger - En entier | 2.4 mg | Not calculated |
| Diastase du malt Source : Diastatic Malt | 1.875 mg | Not calculated |
| Diastase du malt Source : Hordeum vulgare | 1.875 mg | Not calculated |
| Diastase du malt Source : Semence(s) | 1.875 mg | Not calculated |
| Diastase du malt Source : Diastatic Malt | 75 FCC DP° | Not calculated |
| Diastase du malt Source : Hordeum vulgare | 75 FCC DP° | Not calculated |
| Diastase du malt Source : Semence(s) | 75 FCC DP° | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : alpha-Galactosidase | 3 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 3 mg | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Lactase | 3 mg | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae - En entier | 3 mg | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Lactase | 300 FCC ALU | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae - En entier | 300 FCC ALU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 250 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 250 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 250 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 2.5 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 2.5 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 2.5 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 1.75 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 350 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 1.75 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 350 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 1.75 mg | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 350 FCC LU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 7 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 7 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 700 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 700 FCC DU | Not calculated |
Non-medicinal ingredients
Saveur de baies amère, Dioxyde de silicium colloïdal, Xylitol, Inuline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 12 years ; maximum: 18 years | 1 Comprimé | 3 days |
Uses authorised in Canada
Digestive enzymes. Protease helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Headaches, heartburn, flatulence, diarrhoea, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes, galactosemia, phenylketonuria, gastrointestinal lesions/ulcers, are taking anticoagulant agents or anti-inflammatory agents, or are having surgery. Discontinue use and consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are following a low protein diet.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80039979
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.